Table 1.
Cpd | R | R’/Ar | CGP (%)a | Cpd | R | R’/Ar | CGP (%)a |
---|---|---|---|---|---|---|---|
5a | -H | H | 41.70 ± 4.89 | 5r | -Cl | -H | 78.58 ± 0.81 |
5b | -H | 2-Cl | 3.88 ± 6.23 | 5s | -Cl | 4-F | 86.71 ± 5.86 |
5c | -H | 2-NO2 | 79.18 ± 3.46 | 5t | -Cl | 4-OCH3 | −4.75 ± 1.51 |
5d | -H | 3-Cl | 83.23 ± 4.86 | 5u | -CH3 | -H | 9.91 ± 2.26 |
5e | -H | 4-Cl | 39.09 ± 4.17 | 5v | -CH3 | 2-NO2 | 33.21 ± 7.89 |
5f | -H | 4-F | 65.77 ± 7.72 | 5w | -CH3 | 4-F | 85.41 ± 2.89 |
5g | -H | 4-Br | 54.46 ± 3.97 | 5y | -CH3 | 4-Br | 51.05 ± 7.38 |
5h | -H | 2-OH | 35.50 ± 5.15 | 5x | -CH3 | 4-OCH3 | −13.24 ± 3.12 |
5i | -H | 4-OH | 67.09 ± 8.29 | 5z | -CH3 | 4-(NCH3)2 | −12.43 ± 4.66 |
5j | -H | 4-OCH3 | 91.40 ± 9.78 | 6a | -H | 83.73 ± 7.37 | |
5k | -H | 2,3-(OH)2 | 33.40 ± 4.15 | 6b | -H | 84.82 ± 7.72 | |
5l | -H | 2,4-(OH)2 | 10.38 ± 2.44 | 6c | -H | 69.25 ± 4.17 | |
5m | -H | 2,5-(OH)2 | 74.70 ± 6.61 | 6d | -H | 82.31 ± 4.31 | |
5n | -H | 2-OH-4-OCH3 | 2.81 ± 3.61 | 6e | -H | 84.00 ± 6.92 | |
5o | -H | 3-OH-4-OCH3 | 78.68 ± 8.05 | 6f | -H | 77.79 ± 7.49 | |
5p | -H | 2,3,4-(OCH3)3 | 55.67 ± 6.37 | 6g | -H | 88.32 ± 5.28 | |
5q | -H | 3,4,5-(OCH3)3 | 37.76 ± 7.16 | 7a | -H | -H | 85.58 ± 6.17 |
5-FUb | 17.35 ± 9.01 | 7b | -I | -H | −1.99 ± 5.14 |
aCell growth percentage, compounds were assayed at 30 µg/mL; b5-FU: 5-Fluorouracil, a positive control.